Skip to content

Clinical trials

Phase 1 Anxiety Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 1 Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20044
20052
20064
20073
20086
20094
20104
20115
20121
20132
20143
20151
20163
20172
20182
20193
20202
20213
20226
20233
20248
20257
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status7
Withdrawn6
Recruiting6
Terminated5
Active, not recruiting4
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University4
MetroHealth Medical Center3
National Center for Complementary and Integrative Health (NCCIH)3
VA Office of Research and Development3
Brown University2
Massachusetts General Hospital2
Medical University of South Carolina2
National Institute of Mental Health (NIMH)2
Ohio State University2
Soul Medicine Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders82
Stress Disorders, Post-Traumatic11
Pain10
Neoplasms7
Substance-Related Disorders5
Alcoholism4
Depressive Disorder4
Mental Disorders4
Opioid-Related Disorders4
Sleep Initiation and Maintenance Disorders4

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.